Curve Biosciences Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$40M
- Investors
-
10
Curve Biosciences General Information
Description
Developer of chronic disease monitoring software designed to identify disease states through molecular data. The company's platform utilizes a molecular blueprint and intelligence models trained on a tissue atlas to map DNA methylation patterns back to specific organs, providing healthcare providers with clinical testing tools for monitoring liver conditions and chronic disease progression.
Contact Information
Website
www.curvebio.comCorporate Office
- 901 Mariners Island Boulevard
- Suite 700
- San Mateo, CA 94404
- United States
Corporate Office
- 901 Mariners Island Boulevard
- Suite 700
- San Mateo, CA 94404
- United States
Curve Biosciences Timeline
Curve Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 29-Oct-2025 | $40M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 01-May-2024 | Completed | Generating Revenue |
Curve Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-4 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | 1,282,333 | $0.000010 | 8% | $0.72 | $0.72 | 1x | $0.72 | 2.95% |
| Series A-1 | 19,380,809 | $0.000010 | 8% | $0.8 | $0.8 | 1x | $0.8 | 33% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Curve Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Curve Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Curve Biosciences Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Civilization Ventures | Venture Capital | Minority | ||
| First Spark Ventures | Venture Capital | Minority | ||
| LifeX Ventures | Accelerator/Incubator | Minority | ||
| Luma Group | Accelerator/Incubator | Minority | ||
| Angel (individual) | Minority |
Curve Biosciences FAQs
-
When was Curve Biosciences founded?
Curve Biosciences was founded in 2022.
-
Where is Curve Biosciences headquartered?
Curve Biosciences is headquartered in San Mateo, CA.
-
What is the size of Curve Biosciences?
Curve Biosciences has 25 total employees.
-
What industry is Curve Biosciences in?
Curve Biosciences’s primary industry is Decision/Risk Analysis.
-
Is Curve Biosciences a private or public company?
Curve Biosciences is a Private company.
-
What is Curve Biosciences’s current revenue?
The current revenue for Curve Biosciences is .
-
How much funding has Curve Biosciences raised over time?
Curve Biosciences has raised $56M.
-
Who are Curve Biosciences’s investors?
Civilization Ventures, First Spark Ventures, LifeX Ventures, Luma Group, and are 5 of 10 investors who have invested in Curve Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
